Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Farshid Dayyani

Showing results (21-30 of 115) with videos related to

Pageof 12
Sort By:
Plos One|April 2, 2024
Characterization of patients requiring inpatient hospital ethics consults- A single center studyAditya Mahadevan, Armon Azizi, Cyrus Dastur, et al.
Clinical Advances in Hematology & Oncology : H&O|November 4, 2022
The role of cytoreductive surgery and intraperitoneal chemotherapy in gastric cancerStephanie Young, Arsha Ostowari, Jingjing Yu, et al.
Cancer Medicine|September 23, 2024
Associations between language, telehealth, and clinical outcomes in patients with cancer during the COVID-19 pandemicArmon Azizi, Aditya Mahadevan, Jagmeet S Arora, et al.
American Journal of Hematology|February 9, 2008
HIV-associated multicentric Castleman's diseaseJustin Stebbing, Liron Pantanowitz, Farshid Dayyani, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 20, 2016
Diagnostic Performance of Risk of Ovarian Malignancy Algorithm Against CA125 and HE4 in Connection With Ovarian Cancer: A Meta-analysisFarshid Dayyani, Steffen Uhlig, Bertrand Colson, et al.
Journal of Leukocyte Biology|July 2, 2003
Mechanism of glucocorticoid-induced depletion of human CD14+CD16+ monocytesFarshid Dayyani, Kai-Uwe Belge, Marion Frankenberger, et al.
Cancer Medicine|November 4, 2025
Adequate Catchment Area Representation in Cancer Clinical Trials at NCI Designated Cancer Centers: The University of California Irvine ExperienceFrank Lee, Aditya Mahadevan, Armon Azizi, et al.
Cancers|March 14, 2026
Regional Therapies Utilized in Treating Unresectable Colorectal Adenocarcinoma with Peritoneal MetastasesShray Malik, Vanessa Le, Farshid Dayyani, et al.
Journal of Gastrointestinal Oncology|January 24, 2022
Utility of tumor-informed circulating tumor DNA in the clinical management of gastrointestinal malignanciesShannon Zhang, Danielle Brazel, Priyanka Kumar, et al.
The Oncologist|June 1, 2024
A phase II study of cabozantinib and pembrolizumab in advanced gastric/gastroesophageal adenocarcinomas resistant or refractory to immune checkpoint inhibitorsFarshid Dayyani, Joseph Chao, Fa-Chyi Lee, et al.
Pageof 12

Showing results (21-30 of 115) with videos related to

Sort By:
Pageof 12
Plos One|April 2, 2024
Characterization of patients requiring inpatient hospital ethics consults- A single center studyAditya Mahadevan, Armon Azizi, Cyrus Dastur, et al.
Clinical Advances in Hematology & Oncology : H&O|November 4, 2022
The role of cytoreductive surgery and intraperitoneal chemotherapy in gastric cancerStephanie Young, Arsha Ostowari, Jingjing Yu, et al.
Cancer Medicine|September 23, 2024
Associations between language, telehealth, and clinical outcomes in patients with cancer during the COVID-19 pandemicArmon Azizi, Aditya Mahadevan, Jagmeet S Arora, et al.
American Journal of Hematology|February 9, 2008
HIV-associated multicentric Castleman's diseaseJustin Stebbing, Liron Pantanowitz, Farshid Dayyani, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 20, 2016
Diagnostic Performance of Risk of Ovarian Malignancy Algorithm Against CA125 and HE4 in Connection With Ovarian Cancer: A Meta-analysisFarshid Dayyani, Steffen Uhlig, Bertrand Colson, et al.
Journal of Leukocyte Biology|July 2, 2003
Mechanism of glucocorticoid-induced depletion of human CD14+CD16+ monocytesFarshid Dayyani, Kai-Uwe Belge, Marion Frankenberger, et al.
Cancer Medicine|November 4, 2025
Adequate Catchment Area Representation in Cancer Clinical Trials at NCI Designated Cancer Centers: The University of California Irvine ExperienceFrank Lee, Aditya Mahadevan, Armon Azizi, et al.
Cancers|March 14, 2026
Regional Therapies Utilized in Treating Unresectable Colorectal Adenocarcinoma with Peritoneal MetastasesShray Malik, Vanessa Le, Farshid Dayyani, et al.
Journal of Gastrointestinal Oncology|January 24, 2022
Utility of tumor-informed circulating tumor DNA in the clinical management of gastrointestinal malignanciesShannon Zhang, Danielle Brazel, Priyanka Kumar, et al.
The Oncologist|June 1, 2024
A phase II study of cabozantinib and pembrolizumab in advanced gastric/gastroesophageal adenocarcinomas resistant or refractory to immune checkpoint inhibitorsFarshid Dayyani, Joseph Chao, Fa-Chyi Lee, et al.
Pageof 12